Two pharma companies on rethinking drug launches during COVID-19.
A report from CMI/Compas evaluated consumers’ changing habits during the COVID-19 pandemic.
Marketers from GoodRx and Rx Edge Media Network share their insights.
President Trump wanted to know how quickly pharma could have a vaccine or treatment ready for public use.
The FDA granted Pfizer’s Ibrance a label indication based on real-world data from men using the drug off-label to treat their breast cancer.